Skip to main content
2026 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Live Q&A and Polling
Live Q&A and Polling
Social
Social
Industry
Industry
ViewAttendees 1

Rectal Cancer

Malignancy

APP

Meet the Professor Breakfast: MTP-M2 Rectal Cancer - SOLD OUT

Monday, May 11, 2026
6:45 AM - 7:45 AM ET
Invitation/Ticketed Event CME

    Ask the Experts Discussion Leader(s)

  • David Liska, MD

    Associate Professor, Chair
    Department of Colorectal Surgery, Cleveland Clinic
    Cleveland Clinic, Cleveland, Ohio
    Cleveland, OH, United States

    All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. Medtronic: Consultant (Terminated, January 16, 2024)

  • Steven Hunt, MD

    Professor of Surgery
    Washington University School of Medicine
    Washington University
    St. Louis, Missouri, United States

    All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. This individual has no financial relationships to disclose

Registration is required. You will confirm your place by selecting this Meet the Professor under the “Event Fee” option while registering.

CME: 1 hour

This interactive case-based session will explore contemporary management of rectal cancer, highlighting approaches to early-stage and locally advanced disease, organ preservation strategies, the potential of integrating ctDNA into clinical decision-making, and treatment considerations for patients with stage IV disease.

Learning Objectives:

Upon completion of this activity, participants should be able to:
  • Review optimal treatment approaches for early-stage rectal cancer, focusing on accurate staging, the role of multidisciplinary care, local excision and total mesorectal excision.
  • Discuss current strategies for neoadjuvant therapy and organ preservation for locally advanced rectal cancer.
  • Summarize management options for patients with stage IV rectal cancer, including resection of the primary, metastasectomy, and the role of systemic and liver-directed therapies within a multidisciplinary framework.
  • Evaluate the role of circulating tumor DNA (ctDNA) in postoperative surveillance and treatment decision-making for patients with rectal cancer.